Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study

Diabetes Research and Clinical Practice

Volumn 46, Issue 3, 1999, Pages 183-190

  Bode, Bruce W ^a   Gross, Todd M ^b   Thornton, Kay R ^b   Mastrototaro, John J ^b  

^a ATLANTA DIABETES ASSOCIATES   (United States)

^b MiniMed Inc   (United States)

Author keywords

Continuous glucose monitoring; Glycosylated hemoglobin; Intensive diabetes management

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; DEVICE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HEMOGLOBIN DETERMINATION; HOME MONITORING; HUMAN; MALE; REVIEW;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PILOT PROJECTS; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 0032754795     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00113-8     Document Type: Review

References (5)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependant diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
2. Gilmer T.P., O'Connor P.J., Manning W.G., Rush W.A. The cost to health plans of poor glycemic control. Diabetes Care. 20:1997;1847-1855.
3. Clinical practice recommendations. Diabetes Care. 22((Suppl. 1)):1999;S1-S114.
4. J.J. Mastrototaro, The MiniMed Continuous Glucose Monitoring System, J. Pediatr. Endocrinol. Metab. 1999 (in press).
5. Adair J.G. The Hawthorne effect: a reconsideration of the methodological artifact. J. Appl. Psychol. 69:1984;334-345.